Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Smartphone training for caregivers of Alzheimer's patients

Official title: Biobehavioral Mechanisms of Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease

Run by William Marsh Rice University · NCT05949047 · Data updated 2026-11-12

This study tests whether smartphone training can help caregivers of Alzheimer's patients manage stress and improve their emotional well-being.

More Caregivers trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment270 (estimated)
SponsorWilliam Marsh Rice University
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedSeptember 14, 2023
Main results expectedMay 1, 2027
Study endsMay 31, 2027
Registry record updatedMay 29, 2026
Trial IDNCT05949047 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adult unpaid primary caregivers of individuals with Alzheimer's Disease or related dementias who are at least 18 years old and can commit to the intervention.

Probably not a fit

Patients who are not primary caregivers or those who do not meet the inclusion criteria, such as those with significant mental health disorders, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to improve the emotional well-being of unpaid primary caregivers for individuals with Alzheimer's Disease and related dementias through a smartphone-based cognitive emotion regulation intervention. The intervention focuses on teaching caregivers techniques such as psychological distancing and reinterpretation to help them manage stress and depressive symptoms. Participants will be randomly assigned to receive training in one of these techniques or to a control group. The study will also explore the potential benefits of this intervention on the quality of life of the care recipients.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce stress and depressive symptoms in caregivers, leading to improved mental health and caregiving experiences.

How similar studies have gone: Other studies have shown promise in using cognitive emotion regulation techniques for caregivers, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Healthy Adult Caregivers

* Unpaid primary caregiver of patient with Alzheimer's Disease/Alzheimer's Disease and Related Dementias (AD/ADRD)
* At least 18 years of age, with no maximum age, provided that all other inclusion/exclusion criteria are met
* Must be able to speak, read, and write in English
* Must be free of any current or past DSM diagnosis (i.e. healthy adults), with the exception of current or past mood or anxiety disorders or past substance-related disorders (i.e., current or past mood or anxiety disorders and/or past substance-related disorders would not represent an exclusion factor)
* Must have a smartphone. This represents any major iOS or Android-based smartphone. The smartphone will also be used for collection of ecological momentary assessment (EMA) data via SurveySignal.
* Must provide significant level of caregiving to their care recipient
* Must be at least minimally-stressed

Cognitively Impaired Adults

* Must have diagnosed with Alzheimer's Disease/Alzheimer's Disease and Related Dementias (AD/ADRD)
* Must be the care recipient of the primary caregiver who is completing the study
* Must be able to understand and willing to complete a questionnaire and the consent form
* Must have minimum level of dementia symptoms

Exclusion Criteria:

Healthy Adult Caregivers

* Current or past psychiatric disorders (e.g., psychotic and personality disorders) with the exception of current or past mood or anxiety disorders or past substance-related disorders (i.e., current or past mood or anxiety disorders and/or past substance-related disorders would not represent an exclusion factor)
* Currently receiving psychotherapy that specifically addresses caregiver burden/distress or employs cognitive reappraisal as a major component
* Significant visual, auditory, or cognitive impairment that compromises their ability to understand and complete the task
* Caregiver participants who cease meeting inclusion criteria during the study will be dismissed from the study and compensated pro-rata.
* Has formerly participated in a study from our lab involving the same or essentially same design (e.g., former participants who provided pilot/preliminary data for this study)

Cognitively Impaired Adults

* The care recipient does not wish to participate, and/or their caregiver does not want them to participate
* Significant visual, auditory, or cognitive impairment that compromises their ability to understand and complete questionnaires, even with their caregiver's help will exclude them from the study
* Has formerly participated in a study from our lab involving the same or essentially same design (e.g., former participants who provided pilot/preliminary data for this study)

Where it's running

  • Rice University
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Bryan Denny, Ph.D. — William Marsh Rice University
  • Study coordinator: Bryan Denny, Ph.D.
  • Email: btd3@rice.edu
  • Phone: 713-348-8257

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.